Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
about
New developments in the pathology of malignant lymphoma: a review of the literature published from May to August 2017.Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.Liquid biopsy for the identification of intravascular large B-cell lymphoma.Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma.New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies
P2860
Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Non-invasive detection of soma ...... ntral nervous system lymphoma.
@en
type
label
Non-invasive detection of soma ...... ntral nervous system lymphoma.
@en
prefLabel
Non-invasive detection of soma ...... ntral nervous system lymphoma.
@en
P2093
P2860
P356
P1433
P1476
Non-invasive detection of soma ...... entral nervous system lymphoma
@en
P2093
Annie Laquerrière
Catherine Maingonnat
Elena-Liana Veresezan
Fabrice Jardin
Florent Marguet
Hervé Tilly
Jean-Michel Picquenot
Philippe Bertrand
Philippe Ruminy
Stéphane Derrey
P2860
P304
48157-48168
P356
10.18632/ONCOTARGET.18325
P407
P577
2017-07-01T00:00:00Z